{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:48:24Z","timestamp":1767116904823},"reference-count":256,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":510,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.aprim.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T20:01:30Z","timestamp":1349121690000},"page":"727.e1-727.e38","source":"Crossref","is-referenced-by-count":5,"title":["Gu\u00eda de pr\u00e1ctica cl\u00ednica sobre el manejo del paciente con dispepsia. Actualizaci\u00f3n 2012"],"prefix":"10.1016","volume":"44","author":[{"given":"Javier P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Mascort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merc\u00e8","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aprim.2012.05.003_bib0005","series-title":"Elaboraci\u00f3n de Gu\u00edas de Pr\u00e1ctica Cl\u00ednica en el Sistema Nacional de Salud. Manual Metodol\u00f3gico","year":"2007"},{"key":"10.1016\/j.aprim.2012.05.003_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1157\/13109491","article-title":"El sistema GRADE para la toma de decisiones cl\u00ednicas y la elaboraci\u00f3n de recomendaciones y gu\u00edas de pr\u00e1ctica cl\u00ednica","volume":"39","author":"Marzo Castillejo","year":"2007","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2012.05.003_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1157\/13117903","article-title":"[How can we find, design, evaluate and use clinical practice guidelines?.]","volume":"31","author":"Gisbert","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0020","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"Rating quality of evidence and strength of recommendations GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"Rating quality of evidence and strength of recommendations: What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0030","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0035","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/bmj.39504.506319.80","article-title":"Rating quality of evidence and strength of recommendations: Incorporating considerations of resources use into grading recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Rating quality of evidence and strength of recommendations: Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"10.1016\/j.aprim.2012.05.003_bib0045","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2009.06067.x","article-title":"Whither dyspepsia?. A historical perspective of functional dyspepsia, and concepts of pathogenesis and therapy in 2009","volume":"24","author":"Talley","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0050","series-title":"Dyspepsia. A national clinical guideline","year":"2007"},{"key":"10.1016\/j.aprim.2012.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2005.09.019","article-title":"Medical Position Statement: Evaluation of Dyspepsia","volume":"129","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1155\/2005\/674607","article-title":"Evidence-based recommendations for short and long term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool","volume":"19","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0065","unstructured":"Dyspepsia \u2013 Management of Dyspepsia in Adults in Primary Care \u2013 Full Guidelines CG17 2004. London: NICE. Available: http:\/\/www.nice.org.uk\/page.aspx?o=218381. Accessed 10 noviembre de 2010."},{"key":"10.1016\/j.aprim.2012.05.003_bib0070","first-page":"576","article-title":"Management of dyspepsia: Report of a working party","volume":"1","author":"Colin-Jones","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0075","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders: a working team report for the Rome III consensus on functional gastrointestinal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0080","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0085","first-page":"477","article-title":"Organic causes of dyspepsia, and discriminating functional from organic dyspepsia","volume":"15","author":"Kellow","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0090","unstructured":"Longstreth GF. Approach to the patient with dyspepsia. En: Talley NJ, editor. This topic last updated: july 22, 2010. Uptodate. http:\/\/www.uptodate.com\/home\/index.html"},{"key":"10.1016\/j.aprim.2012.05.003_bib0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MCG.0b013e31815591f7","article-title":"Functional dyspepsia: not all roads seem to lead to Rome","volume":"43","author":"van Kerkhoven","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0100","first-page":"3","article-title":"Prevalence of upper gastrointestinal symptoms in the general population: a systematic review","volume":"231","author":"Heading","year":"1999","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.aprim.2012.05.003_bib0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2036.2004.01897.x","article-title":"Systemic review: the prevalence and clinical course of functional dyspepsia","volume":"19","author":"El-Serag","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0110","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v12.i17.2661","article-title":"Epidemiology of functional dyspepsia: a global perspective","volume":"12","author":"Mahadeva","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0115","first-page":"717","article-title":"La prevalencia de la dispepsia en Espa\u00f1a","volume":"103","author":"Caballero Plasencia","year":"1994","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2012.05.003_bib0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","article-title":"AGA technical review: evaluation of dyspepsia. American Gastroenterological Association","volume":"114","author":"Talley","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0125","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJM199811053391907","article-title":"Management of non ulcer dyspepsia","volume":"339","author":"Fisher","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.cgh.2010.05.031","article-title":"What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis","volume":"8","author":"Ford","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0135","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0025-7753(03)74093-7","article-title":"[Prospective validation of a clinical scoring system for the diagnosis of organic dyspepsia]","volume":"121","author":"Barenys","year":"2003","journal-title":"Med Clin (Barc)"},{"issue":"Suppl. 4","key":"10.1016\/j.aprim.2012.05.003_bib0140","first-page":"72","article-title":"Dyspepsia: management guidelines for the millennium","volume":"50","author":"Talley","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2036.2009.04047.x","article-title":"Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia","volume":"30","author":"Hungin","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0150","first-page":"65","article-title":"Variaciones en la frecuencia de las enfermedades cr\u00f3nicas y los factores de riesgo en atenci\u00f3n primaria: 1985-1995","volume":"18","author":"Turabian","year":"1996","journal-title":"Aten Primaria"},{"key":"10.1016\/j.aprim.2012.05.003_bib0155","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cgh.2010.03.003","article-title":"Functional dyspepsia impacts absenteeism and direct and indirect costs","volume":"8","author":"Brook","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000121346","article-title":"Pathogenesis of dyspepsia","volume":"26","author":"Mimidis","year":"2008","journal-title":"Dig Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/11534590-000000000-00000","article-title":"Identification of NSAID users at risk for gastrointestinal complications: a systematic review of current guidelines and consensus agreements","volume":"33","author":"Tielemans","year":"2010","journal-title":"Drug Saf"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1523-5378.2009.00697.x","article-title":"Helicobacter pylori and non-malignant diseases","volume":"14","author":"Furuta","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0175","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Clinical practice. Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0016-5085(82)90116-0","article-title":"Is epigastric tenderness a sign of peptic ulcer disease?","volume":"82","author":"Priebe","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0185","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/fampra\/11.4.382","article-title":"How much ulcer is ulcer-like? Diagnostic determinants of peptic ulcer in open access gastroscopy","volume":"11","author":"Numans","year":"1994","journal-title":"Fam Pract"},{"key":"10.1016\/j.aprim.2012.05.003_bib0190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00042737-200012120-00003","article-title":"Scoring system has better discriminative value than Helicobacter pylori testing in patients with dyspepsia in a setting with high prevalence of infection","volume":"12","author":"Barenys","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0195","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/00365529008997594","article-title":"The predictive value of history in dyspepsia","volume":"25","author":"Johannessen","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0200","first-page":"139","article-title":"Discriminant value of symptoms in patients with dyspepsia","volume":"38","author":"Muris","year":"1994","journal-title":"J Fam Pract"},{"key":"10.1016\/j.aprim.2012.05.003_bib0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00042737-199604000-00014","article-title":"Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement","volume":"8","author":"Bytzer","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/00365529850171431","article-title":"Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping","volume":"33","author":"Hansen","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0215","first-page":"66","article-title":"The prediction of the endoscopic diagnosis in the dyspepsia patient: the value of the predominating presenting symptom and the initial clinical presumption","volume":"23","author":"Bustamante","year":"2000","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/028134300750018981","article-title":"GPs\u2019 ability to diagnose dyspepsia based only on physical examination and patient history","volume":"18","author":"Heikkinen","year":"2000","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.aprim.2012.05.003_bib0225","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.295.13.1566","article-title":"Can the clinical history distinguish between organic and functional dyspepsia?","volume":"295","author":"Moayyedi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.aprim.2012.05.003_bib0230","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0002-9270(01)02338-3","article-title":"Value of the unaided clinical diagnosis in dyspeptic patients in primary care","volume":"96","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0235","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00042737-199708000-00008","article-title":"Reliability of symptom assessment in dyspepsia","volume":"9","author":"Heading","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0016-5107(01)70399-9","article-title":"Accuracy of provisional diagnoses of dyspepsia in patients undergoing first endoscopy","volume":"53","author":"Westbrook","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aprim.2012.05.003_bib0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1067\/mge.2002.122617","article-title":"Empirical treatment based on \u201ctypical\u201d reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection","volume":"55","author":"Wu","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aprim.2012.05.003_bib0250","first-page":"150","article-title":"Prevalencia de esofagitis grave en Espa\u00f1a","volume":"31","author":"Ponce","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0255","unstructured":"Institute for Clinical Systems Improvement. Health Care Guideline: Dyspepsia. Institute for Clinical Systems Improvement, 2002. http:\/\/www.icsi.org\/guide\/Dyspep.pdf"},{"key":"10.1016\/j.aprim.2012.05.003_bib0260","unstructured":"Aymerich M, Baena JM, Boix C, Carrillo R, Madrilejos R, Mascort JJ, et al. Direcci\u00f3 cl\u00ednica en l\u2019atenci\u00f3 prim\u00e0ria. Dispepsia - H. pylori. Guies de pr\u00e0ctica cl\u00ednica i material docent. (Monograf\u00eda en Internet) 2005 (citado enero 2011). Disponible en: http:\/\/www.gencat. net\/ics\/professionals\/guies\/dispepsia\/dispepsia.htm"},{"issue":"12 Suppl","key":"10.1016\/j.aprim.2012.05.003_bib0265","first-page":"S1","article-title":"An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori","volume":"162","author":"Veldhuyzen van Zanten","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0270","article-title":"Stomach Pain \u2013 Evidence-Based Methods in the Diagnosis and Treatment of Dyspepsia","year":"2000","journal-title":"Stockholm"},{"key":"10.1016\/j.aprim.2012.05.003_bib0275","unstructured":"Alberta Clinical Practice Guideline Working Group. Guideline for Diagnosis and Treatment of Chronic Undiagnosed Dyspepsia in Adults. The Alberta Clinical Guideline Program, June 2000."},{"key":"10.1016\/j.aprim.2012.05.003_bib0280","series-title":"Dyspepsia Management Guidelines","year":"2002"},{"key":"10.1016\/j.aprim.2012.05.003_bib0285","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000201325","article-title":"The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopic findings: a study on the clinical presentation of 1,147 patients","volume":"57","author":"Adang","year":"1996","journal-title":"Digestion"},{"key":"10.1016\/j.aprim.2012.05.003_bib0290","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(88)90879-3","article-title":"Do young patients with dyspepsia need investigation?","volume":"2","author":"Williams","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.41.4.513","article-title":"Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia","volume":"41","author":"Christie","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0300","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1572-0241.1999.00774.x","article-title":"Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55?","volume":"94","author":"Gillen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0305","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00042737-199811000-00009","article-title":"A prospective study of the management of the young Helicobacter pylori negative dyspeptic patient\u2212can gastroscopies be saved in clinical practice?","volume":"10","author":"Heaney","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0310","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1572-0241.2002.05536.x","article-title":"Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy","volume":"97","author":"Canga","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0315","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0002-9343(99)00016-9","article-title":"The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review","volume":"106","author":"Ofman","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0320","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.301.6751.513","article-title":"Early detection of gastric cancer","volume":"301","author":"Hallissey","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/bmj.307.6904.591","article-title":"Gastric cancer: a curable disease in Britain","volume":"307","author":"Sue-Ling","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0330","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1155\/2000\/783950","article-title":"The value of alarm features in identifying organic causes of dyspepsia","volume":"14","author":"Madsen","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0335","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/j.1572-0241.2005.00225.x","article-title":"Guidelines for the Management of Dyspepsia","volume":"100","author":"Talley","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/gut.46.1.93","article-title":"Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia","volume":"46","author":"Breslin","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/bmj.314.7079.467","article-title":"Delays in the diagnosis ofoesophagogastric cancer: a consecutive case series","volume":"314","author":"Martin","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0350","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1136\/bmj.317.7173.1606","article-title":"Proton pump inhibitors may mask early gastric cancer. Dyspeptic patients over 45 should undergo endoscopy before thesedrugs are started","volume":"317","author":"Griffin","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0355","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/gut.41.3.308","article-title":"Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study","volume":"41","author":"Suvakovic","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0360","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/gut.46.4.464","article-title":"Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy","volume":"46","author":"Bramble","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0365","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(00)02553-8","article-title":"Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial","volume":"356","author":"Lassen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0370","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2036.1998.00423.x","article-title":"Randomized controlled trial of omeprazole or endoscopy in patients with persistent dyspepsia: a cost-effectiveness analysis","volume":"12","author":"Laheij","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0375","first-page":"1556","article-title":"Helicobacter pylori infection and gastric cancer in Spain","volume":"48","author":"Pajares","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0380","unstructured":"NHS Executive Referral Guidelines for Suspected Cancer. London: HMSO, 2000."},{"key":"10.1016\/j.aprim.2012.05.003_bib0385","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/gut.50.suppl_5.v1","article-title":"Guidelines for the management of oesophageal and gastric cancer","volume":"50","author":"Allum","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0390","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gut.2004.039438","article-title":"Predictive value of alarm features in a rapid access upper gastrointestinal cancer service","volume":"54","author":"Kapoor","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0395","unstructured":"Globocan. http:\/\/globocan.iarc.fr\/factsheets\/populations\/factsheet.asp?uno=724. Accessed 5 julio de 2011."},{"key":"10.1016\/j.aprim.2012.05.003_bib0400","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1155\/2010\/362130","article-title":"Counselling by primary care physicians may help patients with heartburn-predominant uninvestigated dyspepsia","volume":"24","author":"Par\u00e9","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0405","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","article-title":"Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial","volume":"324","author":"Chiba","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0410","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00365520310008674","article-title":"Does the \u2018test-and-treat\u2019 strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients","volume":"39","author":"F\u00e4rkkil\u00e4","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0415","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.45.2.186","article-title":"A prospective randomised trial of a \u201ctest and treat\u201d policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic","volume":"45","author":"Heaney","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.38702.662546.55","article-title":"Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial","volume":"332","author":"Lane","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0425","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1053\/j.gastro.2005.09.016","article-title":"A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial","volume":"129","author":"Ford","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0430","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1365-2036.2010.04363.x","article-title":"Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project","volume":"32","author":"Harvey","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0435","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/003655299750025822","article-title":"Helicobacter pylori test-and-treat\u2019 strategy for dyspeptic patients","volume":"34","author":"Gisbert","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0440","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1083-4389.2004.00195.x","article-title":"The TETRA study: a prospective evaluation of Helicobacter pylori \u2018test-and-treat\u2019 strategy on 736 patients in clinical practice","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0445","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/598198","article-title":"Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal","volume":"48","author":"Calvet","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0450","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.40.4.459","article-title":"A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection","volume":"40","author":"Dom\u00ednguez-Mu\u00f1oz","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0455","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.dld.2005.09.006","article-title":"13C-urea breath test in the management of Helicobacter pylori infection","volume":"37","author":"Gisbert","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0460","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0889-8553(05)70156-4","article-title":"Accurate diagnosis of Helicobacter pylori. 13C-urea breath test","volume":"29","author":"Graham","year":"2000","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.aprim.2012.05.003_bib0465","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2004.02203.x","article-title":"Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review","volume":"20","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0470","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1157\/13123599","article-title":"Manejo de la infecci\u00f3n por Helicobacter pylori en atenci\u00f3n primaria en Espa\u00f1a","volume":"31","author":"Gen\u00e9","year":"2008","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0475","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bmj.326.7399.1118","article-title":"Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment","volume":"326","author":"Manes","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0480","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1111\/j.1572-0241.2002.07123.x","article-title":"A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia","volume":"97","author":"Rabeneck","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0485","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0490","first-page":"CD001961","author":"Delaney","year":"2005","journal-title":"Initial management strategies for dyspepsia Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2012.05.003_bib0495","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1572-0241.2005.40280.x","article-title":"A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study","volume":"100","author":"Veldhuyzen van Zanten","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0500","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(09)60070-2","article-title":"Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial","volume":"373","author":"van Marrewijk","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0505","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7326\/0003-4819-101-4-538","article-title":"Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study","volume":"101","author":"Dooley","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1148\/radiology.163.1.3823455","article-title":"Peptic ulcer and gastric carcinoma: diagnosis with biphasic radiography compared with fiberoptic endoscopy","volume":"163","author":"Shaw","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1148\/radiology.178.1.1984327","article-title":"Detection of Gastric Erosions: Comparison of Biphasic Radiography With Fiberoptic Endoscopy","volume":"178","author":"Shaw","year":"1991","journal-title":"Radiology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0520","series-title":"Making the best use of a Department of Clinical Radiology","year":"1998"},{"key":"10.1016\/j.aprim.2012.05.003_bib0525","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1053\/j.gastro.2005.03.004","article-title":"Helicobacter pylori \u201ctest and treat\u201d or endoscopy for managing dyspepsia: an individual patient data meta-analysis","volume":"128","author":"Ford","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0530","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gut.2007.147728","article-title":"Cost-effectiveness of and satisfaction with a Helicobacter pylori \u201ctest and treat\u201d strategy compared with prompt endoscopy in young Asians with dyspepsia","volume":"57","author":"Mahadeva","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0535","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-2036.2007.03500.x","article-title":"Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use","volume":"26","author":"Ford","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0540","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1067\/mge.2003.308","article-title":"Low yield of endoscopy in patients with persistent dyspepsia taking proton pump inhibitors","volume":"58","author":"Smith","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aprim.2012.05.003_bib0545","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1155\/2010\/379583","article-title":"A one-year economic evaluation of six alternative strategies in the management of uninvestigated upper gastrointestinal symptoms in Canadian primary care","volume":"24","author":"Barkun","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/0272989X07309644","article-title":"A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States","volume":"28","author":"Barton","year":"2008","journal-title":"Med Decis Making"},{"key":"10.1016\/j.aprim.2012.05.003_bib0555","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0266462307070420","article-title":"Cost-effectiveness analysis of two management strategies for dyspepsia","volume":"23","author":"Kjeldsen","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.aprim.2012.05.003_bib0560","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bpg.2006.11.004","article-title":"The health economics of Helicobacter pylori infection","volume":"21","author":"Moayyedi","year":"2007","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0565","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.clinthera.2005.10.011","article-title":"Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting","volume":"27","author":"Klok","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0570","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00042737-200410000-00005","article-title":"Cost-effectiveness and long-term impact of Helicobacter pylori \u2018test and treat\u2019 service in reducing open access endoscopy referrals","volume":"16","author":"Sreedharan","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0575","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/fampra\/cmh304","article-title":"Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting","volume":"21","author":"Laheij","year":"2004","journal-title":"Fam Pract"},{"key":"10.1016\/j.aprim.2012.05.003_bib0580","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1017\/S0266462303000394","article-title":"Cost-effectiveness of alternative approaches in the management of dyspepsia","volume":"19","author":"Makris","year":"2003","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.aprim.2012.05.003_bib0585","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(94)92023-0","article-title":"Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia","volume":"343","author":"Bytzer","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0590","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(00)03308-0","article-title":"Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care","volume":"356","author":"Delaney","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0595","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2036.2008.03784.x","article-title":"Meta-analysis: Helicobacter pylori \u2018test and treat\u2019 compared with empirical acid suppression for managing dispepsia","volume":"28","author":"Ford","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0600","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39479.640486.AE","article-title":"Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)","volume":"336","author":"Delaney","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib0605","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/S0266462306051269","article-title":"Economic evaluation of empirical antisecretory therapy versus Helicobacter pylori test for management of dyspepsia: a randomized trial in primary care","volume":"22","author":"Jarbol","year":"2006","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.aprim.2012.05.003_bib0610","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2036.2002.01306.x","article-title":"Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis","volume":"16","author":"Ladabaum","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0615","first-page":"545","article-title":"Evaluation of the dyspeptic patient: a cost-utility study","volume":"44","author":"Ebell","year":"1997","journal-title":"Fam Pract"},{"key":"10.1016\/j.aprim.2012.05.003_bib0620","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7326\/0003-4819-123-4-199508150-00003","article-title":"Alternative management strategies for patients with suspected peptic ulcer disease","volume":"123","author":"Fendrick","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0625","first-page":"709","article-title":"Cost-effectiveness of a \u201cscore and scope\u201d strategy for the management of dyspepsia","volume":"17","author":"Garc\u00eda-Alt\u00e9s","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0630","first-page":"241","article-title":"Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense","volume":"98","author":"Macenlle Garc\u00eda","year":"2006","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.aprim.2012.05.003_bib0635","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1695-4033(05)70247-2","article-title":"Helicobacter pylori infection in the child population in Spain: prevalence, related factors and influence on growth","volume":"63","author":"Leandro Liberato","year":"2005","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.aprim.2012.05.003_bib0640","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0645","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.bjc.6605024","article-title":"Proton pump inhibitors and risk of gastric cancer: a population-based cohort study","volume":"100","author":"Poulsen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.aprim.2012.05.003_bib0650","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/ajg.2009.172","article-title":"H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole","volume":"104","author":"Yang","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0655","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00042737-199710000-00007","article-title":"Erosive duodenitis: prevalence of Helicobacter pylori infection and response to eradication therapy with omeprazole plus two antibiotics","volume":"9","author":"Gisbert","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0660","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1523-5378.2009.00704.x","article-title":"Treatment of Helicobacter pylori infection","volume":"14","author":"O\u2019Connor","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0665","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MCG.0b013e3181c8a1a3","article-title":"Sequential therapy for Helicobacter pylori eradication: a critical review","volume":"44","author":"Gisbert","year":"2010","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0670","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1523-5378.2010.00774.x","article-title":"Treatment of Helicobacter pylori infection 2010","volume":"15","author":"O\u2019Connor","year":"2010","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0675","doi-asserted-by":"crossref","unstructured":"O\u2019Connor A, Gisbert JP, McNamara D, O\u2019Morain C. Treatment of Helicobacter pylori infection 2011. Helicobacter. 2011;16(Suppl.):53-8.","DOI":"10.1111\/j.1523-5378.2011.00881.x"},{"key":"10.1016\/j.aprim.2012.05.003_bib0680","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0014-2565(00)70664-3","article-title":"Diagnosis of Helicobacter pylori infection","volume":"200","author":"Gisbert","year":"2000","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.aprim.2012.05.003_bib0685","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/0003-4819-129-7-199810010-00007","article-title":"Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori","volume":"129","author":"Laine","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0690","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/00042737-199910000-00010","article-title":"The impact of short-term ranitidine use on the precision of the 13C-urea breath test in subjects infected with Helicobacter pylori","volume":"11","author":"Connor","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0695","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1572-0241.2001.03517.x","article-title":"Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori","volume":"96","author":"Savarino","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0700","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1440-1746.2003.02922.x","article-title":"Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection","volume":"18","author":"Adachi","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0705","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1572-0241.2004.30162.x","article-title":"Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection","volume":"99","author":"Gatta","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0710","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0889-8553(21)00266-1","article-title":"Diagnosis of Helicobacter pylori infection","volume":"22","author":"Brown","year":"1993","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.aprim.2012.05.003_bib0715","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1746.2008.05679.x","article-title":"Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer","volume":"24","author":"Kim","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0720","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mge.2000.105776","article-title":"Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori","volume":"51","author":"Laine","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.aprim.2012.05.003_bib0725","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00042737-200402000-00012","article-title":"Evaluation of a new biopsy urease test: Pronto Dry, for the diagnosis of Helicobacter pylori infection","volume":"16","author":"Said","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0730","first-page":"475","article-title":"[Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease]","volume":"200","author":"Bermejo San Jose","year":"2000","journal-title":"Rev Clin Esp"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0735","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.11.s1.2.x","article-title":"Endoscopic methods for the diagnosis of Helicobacter pylori","volume":"11","author":"Cohen","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0740","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1016\/S0002-9343(96)80227-0","article-title":"Testing for Helicobacter pylori in clinical practice","volume":"100","author":"Cutler","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0745","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/JCM.36.10.2803-2809.1998","article-title":"Evaluation of commercially available Helicobacter pylori serology kits: a review","volume":"36","author":"Laheij","year":"1998","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 2","key":"10.1016\/j.aprim.2012.05.003_bib0750","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/fampra\/17.suppl_2.S12","article-title":"Tests for Helicobacter pylori infection: a critical appraisal from primary care","volume":"17","author":"Roberts","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.aprim.2012.05.003_bib0755","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1523-5378.1999.09025.x","article-title":"Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori","volume":"4","author":"Cohen","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0760","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s100960050454","article-title":"Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy","volume":"19","author":"Herbrink","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0765","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.40.4.459","article-title":"A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection","volume":"40","author":"Dominguez-Mu\u00f1oz","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0770","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4321\/S1130-01082005000500007","article-title":"Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference","volume":"97","author":"Mones","year":"2005","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.aprim.2012.05.003_bib0775","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1083-4389.2004.00235.x","article-title":"Stool antigen test for the diagnosis of Helicobacter pylori infection: a systematic review","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0780","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0785","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1086\/649860","article-title":"Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia","volume":"50","author":"Calvet","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0790","unstructured":"Malfertheiner et al. Maastricht consensus report IV, datos no publicados.(en prensa)."},{"key":"10.1016\/j.aprim.2012.05.003_bib0795","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ajg.2008.87","article-title":"pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen","volume":"104","author":"Rokkas","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0800","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2036.2007.03573.x","article-title":"Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients","volume":"27","author":"Gisbert","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0805","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0210-5705(11)70003-6","article-title":"Enfermedades relacionadas con H. pylori: dispepsia, \u00falcera y c\u00e1ncer g\u00e1strico","volume":"34","author":"Gisbert","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0810","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMc1006158","article-title":"Helicobacter pylori infection","volume":"363","author":"Graham","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0815","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/gut.2009.192757","article-title":"Helicobacter pylori treatment in the era of increasing antibiotic resistance","volume":"59","author":"Graham","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0820","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"Megraud","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0825","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0830","first-page":"236","article-title":"Resistencia de Helicobacter pylori a diversos antibi\u00f3ticos: un estudio multic\u00e9ntrico espa\u00f1ol","volume":"34","author":"P\u00e9rez-Trallero","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0835","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1365-2036.2003.t01-1-01712.x","article-title":"Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis","volume":"18","author":"Gene","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0840","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.2003.01566.x","article-title":"Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis","volume":"17","author":"Gene","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0845","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"Luther","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0850","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(11)60020-2","article-title":"Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial","volume":"377","author":"Malfertheiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0855","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gut.2007.125658","article-title":"The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis","volume":"56","author":"Zullo","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib0860","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0140-6736(07)61455-X","article-title":"Sequential regimens for Helicobacter pylori eradication","volume":"370","author":"Moayyedi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.aprim.2012.05.003_bib0865","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1038\/ajg.2009.555","article-title":"Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children","volume":"104","author":"Gatta","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0870","first-page":"189","article-title":"Meta-an\u00e1lisis de la terapia secuencial frente a la triple terapia cl\u00e1sica para la erradicaci\u00f3n de Helicobacter pylori","volume":"34","author":"Gisbert","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0875","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/j.1572-0241.2008.01924.x","article-title":"Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice","volume":"103","author":"S\u00e1nchez-Delgado","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0880","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2036.2010.04274.x","article-title":"Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication","volume":"31","author":"Molina-Infante","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0885","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1523-5378.2009.00671.x","article-title":"Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing \u201cconcomitant therapy\u201d versus triple therapy for Helicobacter pylori eradication","volume":"14","author":"Essa","year":"2009","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib0890","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2009.09.030","article-title":"Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection","volume":"8","author":"Wu","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0895","first-page":"179","article-title":"Eficacia del tratamiento emp\u00edrico cu\u00e1druple \u201cconcomitante\u201d para la infecci\u00f3n por H. pylori en un \u00e1rea con una tasa elevada de resistencia a claritromicina","volume":"34","author":"Molina-Infante","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0900","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2036.2011.04770.x","article-title":"Review article: Non-bismuth quadruple (concomitant) therapy for Helicobater pylori eradication","author":"Gisbert","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0905","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1157\/13078424","article-title":"[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]","volume":"125","author":"Gisbert","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2012.05.003_bib0910","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02687.x","article-title":"Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin","volume":"22","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0915","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.dld.2009.06.007","article-title":"Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin","volume":"42","author":"Gisbert","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aprim.2012.05.003_bib0920","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0925","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0025-7753(01)71738-1","article-title":"[Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review]","volume":"116","author":"Gisbert","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2012.05.003_bib0930","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10620-005-2549-1","article-title":"High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin","volume":"50","author":"Rodriguez-Torres","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aprim.2012.05.003_bib0935","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.2002.01270.x","article-title":"Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis","volume":"16","author":"Vallve","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0940","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1572-0241.2006.00717.x","article-title":"The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis","volume":"101","author":"Padol","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0945","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"Villoria","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0950","doi-asserted-by":"crossref","unstructured":"McNicholl AG, Mu\u00f1oz Linares P, P\u00e9rez Nyssen O, Calvet X, Gisbert JP. Meta-analysis: rabeprazole and esomeprazole in the eradication of Helicobacter pylori. Helicobacter 2011, en prensa.","DOI":"10.1016\/S0016-5085(11)63659-7"},{"key":"10.1016\/j.aprim.2012.05.003_bib0955","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. B","key":"10.1016\/j.aprim.2012.05.003_bib0960","doi-asserted-by":"crossref","first-page":"36B","DOI":"10.1155\/2003\/714124","article-title":"How can the current strategies for Helicobacter pylori eradication therapy be improved?","volume":"17","author":"Ford","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0965","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication","volume":"147","author":"Fuccio","year":"2007","journal-title":"Ann Intern Med"},{"issue":"Suppl. 1","key":"10.1016\/j.aprim.2012.05.003_bib0970","first-page":"M1138","article-title":"Duration of Proton-Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication: a Meta-Analysis","volume":"138","author":"Flores","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib0975","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7326\/0003-4819-148-8-200804150-00009","article-title":"Could increasing the duration of triple therapy be a clinically useful strategy?","volume":"148","author":"Calvet","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib0980","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.2002.01276.x","article-title":"Review article: Helicobacter pylori \u201crescue\u201d regimen when proton pump inhibitor-based triple therapies fail","volume":"16","author":"Gisbert","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib0985","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.3748\/wjg.14.5385","article-title":"\u201cRescue\u201d regimens after Helicobacter pylori treatment failure","volume":"14","author":"Gisbert","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0990","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1572-0241.2007.01500.x","article-title":"Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib0995","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","article-title":"Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure","volume":"23","author":"Gisbert","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1000","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1572-0241.2006.00637.x","article-title":"Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis","volume":"101","author":"Saad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1005","first-page":"235","article-title":"Metaan\u00e1lisis de triple terapia con levofloxacino vs. cu\u00e1druple terapia con bismuto como tratamientos de rescate de segunda l\u00ednea para la erradicaci\u00f3n de Helicobacter pylori","volume":"34","author":"Mar\u00edn","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1010","first-page":"234","article-title":"Terapia de rescate con levofloxacino tras el fracaso erradicador de H. pylori: estudio multic\u00e9ntrico de la Asociaci\u00f3n Espa\u00f1ola de Gastroenterolog\u00eda sobre la eficacia y evoluci\u00f3n temporal en 830 pacientes","volume":"34","author":"Gisbert","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MCG.0b013e3181d06b41","article-title":"How to manage Helicobacter pylori after sequential therapy failure?","volume":"44","author":"Zullo","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1020","unstructured":"Gisbert JP, Vinagre-Rodriguez G, Mar\u00edn AC, Molina-Infante J. Second-line rescue triple therapy with levofloxacin after quadruple non-bismuth \u201csequential\u201d or \u201cconcomitant\u201d treatment failure. Helicobacter. En prensa."},{"key":"10.1016\/j.aprim.2012.05.003_bib1025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1572-0241.2006.00457.x","article-title":"Third-line rescue therapy with levofloxacin after two H. pylori treatment failures","volume":"101","author":"Gisbert","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1030","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1365-2036.2003.01592.x","article-title":"Review article: the treatment of refractory Helicobacter pylori infection","volume":"17","author":"Megraud","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2036.2001.00909.x","article-title":"Rifabutin-based Helicobacter pylori eradication \u2018rescue therapy\u2019","volume":"15","author":"Canducci","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1523-5378.2003.00128.x","article-title":"\u201cRescue\u201d therapy with rifabutin after multiple Helicobacter pylori treatment failures","volume":"8","author":"Gisbert","year":"2003","journal-title":"Helicobacter"},{"key":"10.1016\/j.aprim.2012.05.003_bib1045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1365-2036.2006.03149.x","article-title":"Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures","volume":"24","author":"Gisbert","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bmj.312.7027.349","article-title":"Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication","volume":"312","author":"Phull","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib1055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1365-2036.2005.02418.x","article-title":"Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?","volume":"21","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2036.2003.01402.x","article-title":"Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori?. A randomized, controlled, prospective study","volume":"17","author":"Higuchi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2036.2000.00803.x","article-title":"Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage","volume":"14","author":"Lai","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1070","first-page":"236","article-title":"Erradicaci\u00f3n de H. pylori y prevenci\u00f3n de la recidiva hemorr\u00e1gica por \u00falcera p\u00e9ptica. Estudio multic\u00e9ntrico nacional a largo plazo en 890 pacientes","volume":"34","author":"Gisbert","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11938-007-0069-0","article-title":"Functional dispepsia: A new Rome III paradigm","volume":"10","author":"Halder","year":"2007","journal-title":"Current Treatment Options in Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1080","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3748\/wjg.v12.i17.2672","article-title":"Functional dyspepsia: The role of visceral hypersensitivity in its patog\u00e9nesis","volume":"12","author":"Keohane","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1085","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bpg.2004.04.007","article-title":"Pathophysiology of functional dyspepsia","volume":"18","author":"Lee","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1090","first-page":"21","article-title":"Trastornos funcionales y motores digestivos","volume":"3","author":"Mearin","year":"2005","journal-title":"Gastroenterol Hepatol Monogr"},{"key":"10.1016\/j.aprim.2012.05.003_bib1095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2005.04.012","article-title":"Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study","volume":"129","author":"Mearin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1100","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00535-006-1966-z","article-title":"Recent insights into digestive motility in functional dyspepsia","volume":"41","author":"Mizuta","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1105","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1023\/B:DDAS.0000007856.71462.6c","article-title":"Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without helicobacter pylori","volume":"48","author":"Sarnelli","year":"2003","journal-title":"Digestiva Diseases and Sciences"},{"key":"10.1016\/j.aprim.2012.05.003_bib1110","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1053\/gast.1996.v110.pm8612991","article-title":"Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia","volume":"110","author":"Stanghellini","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","article-title":"Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia","volume":"121","author":"Tack","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1120","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/gast.2002.33663","article-title":"Clinical and pathophysiological characteristics of acute-onset functional dyspepsia","volume":"122","author":"Tack","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.51.suppl_1.i63","article-title":"Pathophysiology of functional dyspepsia","volume":"51","author":"Thumshirm","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib1130","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/archinte.160.8.1192","article-title":"Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia","volume":"160","author":"Danesh","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib1135","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bmj.319.7216.1040","article-title":"Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis","volume":"319","author":"Jaakkimainen","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.aprim.2012.05.003_bib1140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-134-5-200103060-00008","article-title":"Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials","volume":"134","author":"Laine","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib1145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0025-7753(02)72403-2","article-title":"Infecci\u00f3n por Helicobacter pylori y dispepsia funcional. Metaan\u00e1lisis de la eficacia del tratamiento erradicador","volume":"118","author":"Gisbert","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.aprim.2012.05.003_bib1150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2036.2001.00903.x","article-title":"Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia","volume":"15","author":"Hsu","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gut.52.1.40","article-title":"Treatment of Helicobacter pylori in functional dispepsia resistant to conventional management: a double blind randomised trial with a six month follow up","volume":"52","author":"Koelz","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib1160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.2004.01878.x","article-title":"Systematic review: the methodological quality of trials affects estimates of treatment efficacy in functional (nonulcer) dyspepsia","volume":"19","author":"Abraham","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1165","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1111\/j.1572-0241.2003.08724.x","article-title":"An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews","volume":"98","author":"Moayyedi","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1170","first-page":"CD002096","article-title":"Eradication of Helicobacter pylori for non-ulcer dyspepsia. [update of Cochrane Database Syst Rev 2001;CD002096 PMID 11279751]","author":"Moayyedi","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2012.05.003_bib1175","first-page":"CD001960","article-title":"Pharmacological interventions for non-ulcer dyspepsia","author":"Moayyedi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2012.05.003_bib1180","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1046\/j.1365-2036.2001.01044.x","article-title":"H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials","volume":"15","author":"Redstone","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1185","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cgh.2006.09.012","article-title":"Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials","volume":"5","author":"Wang","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/gut.50.suppl_4.iv36","article-title":"The potential role of acid suppression in functional dyspepsia: the BOND OPERA PILOT and ENCORE studies","volume":"50","author":"Talley","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.aprim.2012.05.003_bib1195","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1746.2006.04493.x","article-title":"Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia","volume":"22","author":"Hiyama","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1200","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1440-1746.2006.04723.x","article-title":"Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials","volume":"22","author":"Hiyama","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1205","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.coph.2008.09.009","article-title":"Prokinetics and fundic relaxants in upper functional GI disorders","volume":"8","author":"Tack","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(99)00299-5","article-title":"Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis","volume":"108","author":"Jackson","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.aprim.2012.05.003_bib1215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2003.01469.x","article-title":"Influence of the selective serotonin re uptake inhibitor, paroxetine, on gastric sensorimotor function in humans","volume":"17","author":"Tack","year":"2003","journal-title":"Aliment Phamacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/egh.09.73","article-title":"Antidepressants in functional dyspepsia","volume":"4","author":"Talley","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1225","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00535-005-1687-8","article-title":"Treatment of functional dyspepsia with anxiety or antidepressive agents: systematic review","volume":"40","author":"Hojo","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1230","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","article-title":"Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"Van Kerkhoven","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1235","first-page":"CD002301","article-title":"Psychological interventions for non-ulcer dyspepsia","author":"Soo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.aprim.2012.05.003_bib1240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1157\/13079000","article-title":"Tratamiento con antidepresivos en los trastornos funcionales digestivos","volume":"28","author":"Bixquert-Jim\u00e9nez","year":"2005","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1245","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.bpg.2004.04.003","article-title":"Functional dyspepsia: drugs for new (and old) therapeutic targets","volume":"18","author":"Cremonini","year":"2004","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"key":"10.1016\/j.aprim.2012.05.003_bib1250","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2006.03005.x","article-title":"Current and emerging therapies for functional dyspepsia","volume":"24","author":"Saad","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1255","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1365-2036.2007.03277.x","article-title":"Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?","volume":"25","author":"Haag","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1260","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1046\/j.1365-2036.2002.01339.x","article-title":"Systematic review: herbal medicinal products for non-ulcer dyspepsia","volume":"16","author":"Thompson","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1265","first-page":"1027","article-title":"Peppermint oil","volume":"75","author":"Kliger","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.aprim.2012.05.003_bib1270","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1365-2036.2004.02275.x","article-title":"Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)","volume":"20","author":"Melzer","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aprim.2012.05.003_bib1275","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1572-0241.2006.01183.x","article-title":"STW 5, a Phytopharmacon for Patients With Functional Dyspepsia: Results of a Multicenter, Placebo-Controlled Double-Blind Study","volume":"102","author":"Von Arnim","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aprim.2012.05.003_bib1280","article-title":"Acupuncture for functional dyspepsia. Cochrane Database of Systematic","author":"Lan","year":"2010","journal-title":"Reviews"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656712001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656712001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T23:11:13Z","timestamp":1714432273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656712001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":256,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0212656712001874"],"URL":"https:\/\/doi.org\/10.1016\/j.aprim.2012.05.003","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}